Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins

Blood

Volumn 89, Issue 9, 1997, Pages 3166-3174

  Barber, Dwayne L ^a,d   Mason, Jacqueline M ^a   Fukazawa, Toru ^b   Reedquist, Kris A ^c   Druker, Brian J ^b   Band, Hamid ^a,c   D'Andrea, Alan D ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; INTERLEUKIN 3;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG RECEPTOR BINDING; ERYTHROID CELL; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY;

EID: 0030969634     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3166     Document Type: Article

References (74)

1. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59, 1995
2. Lin C-S, Lim S-K, D'Agati V, Constantin! F: Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes De v 10:154, 1996
3. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227, 1993
4. Barber DL, D'Andrea AD: Erythropoietin and interIeukin-2 activate distinct JAK kinase family members. Mol Cell Biol 14:6506, 1994
5. Damen JE, Wakao H, Miyajima A, KrosI J, Humphries RK, Cutler RL, Krystal G: Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and StatS activation. EMBO J 14:5557, 1995
6. Gobert S, Chretien S, Gouilleux F, Muller O, Pallard C, Dusanter-Fourt I, Groner B, Lacombe C, Gisselbrecht S, Mayeux P: Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STATS activation. EMBO J 15:2434, 1996
7. Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weinstein Y, Ihle JN: Erythropoietin induces activation of StatS through association with specific tyrosine on the receptor that are not required for a mitogenic response. Mol Cell Biol 16:1622, 1996
8. Klingmuller U, Bergelson S, Hsiao JG, Lodish HF: Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STATS. Proc Nat! Acad Sei USA 93:8324, 1996
9. Tauchi T, Feng GS, Shen R, Hoatlin M, Bagby GJ, Kabat D, Lu L, Broxmeyer HE: Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem 270:5631, 1995
10. Tauchi T, Damen JE, Toyama K, Feng G-S, Broxmeyer HE, Krystal G: Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood 87:4495, 1996
11. Damen JE, Liu L, Cutler RL, Krystal G: Erythropoietin stimulates the tyrosine phosphorylation of She and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82:2296, 1993
12. Cutler RL, Liu L, Damen JE, Krystal G: Multiple cytokines induce the tyrosine phosphorylation of She and its association with Grb2 in hemopoietic cells. J Biol Chem 268:21463, 1993
13. Miura Y, Miura O, Ihle JN, Aoki N: Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 269:29962, 1994
14. He TC, Jiang N, Zhuang H, Wojchowski DM: Erythropoietininduced recruitment of She via a receptor phosphotyrosine-independent, Jak2-associated pathway. J Biol Chem 270:11055, 1995
15. Barber DL, Corless CN, Xia K, Roberts TM, D'Andrea AD: Erythropoietin activates Rafl by a She independent pathway in CTLL-EPO-R cells. Blood 89:55, 1997
16. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Ratnofsky S, Feldman RA, Cantley LC: Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 14:2777, 1994
17. Lanfrancone L, Pelicci G, Brizzi MF, Arouica MG, Casciari C, Giuli S, Pegoraro L, Pawson T, Pelicci PG: Overexpression of She proteins potentiates the proliferative response to the granulocytemacrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the beta receptor subunit. Oncogene 10:907, 1995
18. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA: Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45, 1993
19. Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D: The SH2 and SH3 domains of mammalian Grb2 couple the EOF receptor to the Ras activator mSosl. Nature 363:83, 1993
20. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar SD, Margolis B, Schlessinger J: Guanine-nucleotide-releasing factor hSosl binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363:85, 1993
21. Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, Bar-Sagi D: Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363:88, 1993
22. Buday L, Downward J: Epidermal growth factor regulates p21 ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73:611, 1993
23. Baltensperger K, Kozma LM, Cherniack AD, Klarlund JK, Chawla A, Banerjee U, Czech MP: Binding of the Ras activator Son of Sevenless to insulin receptor substrate-1 signaling complexes. Science 260:1950, 1993
24. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J: The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953, 1993
25. Carlesso N, Frank DA, Griffin JD: Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811, 1996
26. Matsuguchi T, Salgia R, Hallek M, Eder M, Druker B, Ernst TJ, Griffin JD: She phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin3, and steel factor and is constitutively increased by p210BCR/ABL. J Biol Chem 269:5016, 1994
27. Tauchi T, Feng OS, Shen R, Song HY, Donner D, Pawson T, Broxmeyer HE: SH2-containing phosphotyrosine phosphatase Syp is a target of p210Bcr/Abl tyrosine kinase. J Biol Chem 269:15381, 1994
28. Salgia R, Uemura N, Okuda K, Li J-L, Pisick E, Sattler M, long RD, Druker B, Heisterkamp N, Chen LB, Groffen J, Griffen JD: CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J Biol Chem 270:29145, 1995
29. Matsuguchi T, Inhorn R, Carlesso N, Xu G, Druker B, Griffin JD: Tyrosine phosphorylation of p95VAV in myeloid cells is regulated by GM-CSF, IL-3, and steel factor and is constitutively increased by p210 Bcr/Abl. EMBO J 14:257, 1995
30. de Jong R, ten Hoeve J, Heisterkamp N, Groffen J: Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia. J Biol Chem 270:21468, 1995
31. Ribon V, Hubbell S, Herrera R, Saltiel AR: The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. Mol Cell Biol 16:45,1996
32. Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li J-L, Prasad KV, Griffin JD: The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK like c-ABL, p190 BCR/ABL and p210BCR/ABL to the phosphatidylinositoI-3′ kinase pathway. Oncogene 12:839, 1996
33. ten Hoeve J, Kaartinen V, Fioretos T, Haataja L, Voncken JW, Heisterkamp N, Groffen J: Cellular interactions of CRKL, and SH2-SH3 adaptor protein. Cancer Res 54:2563, 1994
34. ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N, Groffen J: Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood 84:1731, 1994
35. Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ: Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem 269:32740, 1994
36. Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P, Golde DW: Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood 84:2912, 1994
37. Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse III HC: v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc Natl Acad Sei USA 86:1168, 1989
38. Blake TJ, Shapiro M, Morse III HC, Langdon WY: The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653, 1991
39. Donovan JA, Wange RL, Langdon WY, Samelson LE: The protein product of the c-cbl protooncogene is the 120-kDa tyrosinephosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem 269:22925, 1994
40. Meisner H, Conway BR, Hartley D, Czech MP: Interactions of Cbl with Grb2 and phosphatidylinositol 3'-kinase in activated Jurkat cells. Mol Cell Biol 15:3571, 1995
41. Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE, Band H: The SH3 domainbinding T cell tyrosyl phosphoprotein p 120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J Biol Chem 270:19141, 1995
42. Fournel M, Davidson D, Weil R, Veillette A: Association of tyrosine protein kinase Zap-70 with the protooncogene product pl20c-cbl in T lymphocytes. J Exp Med 183:301, 1996
43. Cory GO, Lovering RC, Hinshelwood S, MacCarthy ML, Levinsky RJ, Kinnon C: The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Clin Invest 87:915, 1991
44. cbl in antigen receptor-ligated B cells. J Biol Chem 270:27504, 1995
45. Panchamoorthy G, Fukazawa T, Miyake S, Soltoff S, Reedquist K, Druker B, Shoelson S, Cantley L, Band H: pllOcbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation, and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and She adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 271:3187, 1996
46. Tezuka T, Umemori H, Fusaki N, Yagi T, Takata M, Kurosaki T, Yamamoto T: Physical and functional association of the cbl protooncogene product with an src-family protein tyrosine kinase, p53/ p561yn, in the B cell antigen receptor-mediated signaling. J Exp Med 183:675, 1996
47. Smit L, Horst Gvd, Borst J: Sos, vav and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. J Biol Chem 271:8564, 1996
48. Galisteo ML, Dikic I, Batzer AG, Langdon WY, Schlessinger J: Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EOF) receptor upon EOF, stimulation. J Biol Chem 270:20242, 1995
49. Meisner H, Czech MP: Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor. J Biol Chem 270:25332, 1995
50. cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermial growth factor in PC12 and other cells. J Biol Chem 271:563, 1996
51. Bowtell DDL, Langdon WY: The protein product of the c-cbl oncogene rapidly complexes with the EOF receptor and is tyrosine phosphorylated following EGF stimulation. Oncogene 11:1561, 1995
52. Levkowitz G, Klapper LN, Tzahar E, Freywald A, Sela M, Yarden Y: Coupling of the c-Cbl protooncogene product to ErbB-1/ EGF-receptor but not to other ErbB proteins. Oncogene 12:1117, 1996
53. Fukazawa T, Miyake S, Band V, Band H: Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signalling proteins. J Biol Chem 271:14554, 1996
54. Tanaka S, Neff L, Baron R, Levy JB: Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem 270:14347, 1995
55. Wang Y, Yeung Y-G, Langdon WY, Stanley ER: c-cbl is transiently tyrosine-phosphorylated, ubiquintinated, and membranetargeted following CSF-1 stimulation of macrophages. J Biol Chem 271:17, 1996
56. Marcilla A, Riverolezcano OM, Agarwal A, Robbins KC: Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fey receptors. J Biol Chem 270:9115,1995
57. Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y, Hirai H: The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grt2/Ash in human hematopoietic cells. J Biol Chem 270:10800, 1995
58. Mayer BJ, Hamaguchi M, Hanafusa H: A novel viral oncogene with structural similarity to phospholipase C. Nature 332:272, 1988
59. Tsuchie H, Chang CH, Yoshida M, Vogt PK: A newly isolated avian sarcoma virus, ASV-1, carries the crk oncogene. Oncogene 6:653, 1991
60. Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M: Two species of human CRK cDNA encode proteins with distinct biological activities. Lancet 337:987, 1991
61. ten Hoeve J, Morris C, Heisterkamp N, Groffen J: Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene 8:2853, 1993
62. Gotoh T, Hattori S, Nakamura S, Kitayama H, Noda M, Takai Y, Kaibuchi K, Matsui H, Hatas O, Takahashi H, Kurata T, Matsuda M: Identification of Rapl as a target for the Crk SH2 domain-binding guanine nucleotide-releasing factor C3G. Mol Cell Biol 15:6746, 1995
63. Buday L, Khwaja A, Sipeki S, Farago A, Downward J: Interactions of Cbl with two adaptor proteins, Grb2 and Crk, upon T cell activation. J Biol Chem 271:6159, 1996
64. Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H: Stimulation through the T cell receptor induces Cbl association with Crk proteins and guanine nucleotide exchange protein C3G. J Biol Chem 271:8435, 1996
65. Sawasdikosol S, Chang J-H, Pratt JC, Wolf G, Shoelson SE, Burakoff SJ: Tyrosine-phosphorylated Cbl binds to Crk after T cell activation. J Immunol 151:110, 1996
66. Barber DL, DeMartino JC, Showers MO, D'Andrea AD: A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation. Mol Cell Biol 14:2257, 1994
67. Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G: The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sei USA 93:1689, 1996
68. Kavanaugh WM, Pot DA, Chin SM, Deuter-Reinhard M, Jefferson AB, Noms FA, Masiarz FR, Cousens LS, Majerus PW, Williams LT: Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with She and Grb2. Curr Biol 6:438, 1996
69. Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold R, Rohrschneider LR: plSOShip, a signal transduction molecule with inositol poIyphospate-5-phosphatase activity. Genes Dev 10:1084, 1996
70. Tanaka S, Morishita T, Hashimoto Y, Hattori S, Nakamura S, Shibuya M, Matuoka K, Takenawa T, Kurata T, Nagashima K, Matsuda M: C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of Crk and Grb2/ Ash proteins. Proc Natl Acad Sei USA 91:3443, 1994
71. Cherniack AD, Klarlund JK, Conway BR, Czech MP: Disassembly of Son-of-sevenless proteins from Grb2 during p21ras desensitization by insulin. J Biol Chem 270:1485, 1995
72. Waters SB, Yamauchi K, Pessin JE: Insulin-stimulated disassociation of the SOS-Grb2 complex. Mol Cell Biol 15:2791, 1995
73. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC: SH2 domains recognize specific phosphopeptide sequences. Cell 72:767, 1993
74. Sawasdikosol S, Ravichandran KS, Lee KK, Chang JH, Burakoff SJ: Crk interacts with tyrosine-phosphorylated pi 16 upon T cell activation. J Biol Chem 270:2893, 1995